Nanoscale,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Esophageal
squamous
cell
carcinoma
(ESCC)
is
an
aggressive
malignancy
characterized
by
limited
treatment
options
and
poor
prognosis.
Nanoparticle-based
drug
delivery
systems
have
emerged
as
a
promising
strategy
to
enhance
cancer
therapy
efficacy
improving
targeting,
reducing
toxicity,
enabling
multifunctional
applications.
This
review
highlights
some
key
types
of
nanoparticles,
including
liposomes,
polymeric
metallic
dendrimers,
quantum
dots,
which
could
effectively
improve
the
various
drugs
used
in
chemotherapy,
radiotherapy,
immunotherapy,
offering
more
precise
effective
options.
With
ability
stability
overcome
biological
barriers,
nanoparticle-based
represent
transformative
for
ESCC
treatment.
Despite
challenges,
such
biocompatibility
scalability,
future
holds
great
promise,
particularly
development
personalized
nanomedicine
novel
therapeutic
approaches
targeting
tumor
microenvironment.
ongoing
advancements,
hold
immense
potential
revolutionize
patient
outcomes.
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(26)
Published: June 28, 2024
Oral
medication
for
ulcerative
colitis
(UC)
is
often
hindered
by
challenges
such
as
inadequate
accumulation,
limited
penetration
of
mucus
barriers,
and
the
intricate
task
mitigating
excessive
ROS
inflammatory
cytokines.
Here,
we
present
a
strategy
involving
sodium
alginate
microspheres
(SAMs)
incorporating
M2
macrophage
membrane
(M2M)-coated
Janus
nanomotors
(denominated
Motor@M2M)
targeted
treatment
UC.
SAM
provides
protective
barrier,
ensuring
that
Motor@M2M
withstands
harsh
gastric
milieu
exhibits
controlled
release.
M2M
enhances
targeting
precision
to
tissues
acts
decoy
neutralization
Catalytic
decomposition
H
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(11), P. 8229 - 8247
Published: March 1, 2024
Endothelial–mesenchymal
transition
(EndoMT)
of
vascular
endothelial
cells
has
recently
been
considered
as
a
key
player
in
the
early
progression
variety
and
nonvascular
diseases,
including
atherosclerosis,
cancer,
organ
fibrosis.
However,
current
strategies
attempting
to
identify
pharmacological
inhibitors
block
regulatory
pathways
EndoMT
suffer
from
poor
selectivity,
unwanted
side
effects,
heterogeneous
response
with
different
origins.
Furthermore,
focus
on
preventing
EndoMT,
leaving
that
have
already
undergone
unresolved.
Here,
we
report
design
simple
but
powerful
nanoparticle
system
(i.e.,
N-cadherin
targeted
melanin
nanoparticles)
convert
cytokine-activated,
mesenchymal-like
back
their
original
phenotype.
We
term
this
process
"Reversed
EndoMT"
(R-EndoMT).
R-EndoMT
allows
impaired
barriers
recover
quiescence
intactness,
significantly
reduced
leukocyte
cancer
cell
adhesion
transmigration,
which
could
potentially
stop
atheromatous
plaque
formation
metastasis
stages.
is
achieved
types
originating
arteries,
veins,
capillaries,
independent
activating
cytokines.
reveal
nanoparticles
reverse
by
downregulating
an
dependent
RhoA
activation
pathway.
Overall,
approach
offers
prospect
treat
multiple
EndoMT-associated
diseases
designing
phenotypical
cells.
Small,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 27, 2024
Abstract
Reactive
oxygen
species
(ROS)‐mediated
emerging
treatments
exhibit
unique
advantages
in
cancer
therapy
recent
years.
While
the
efficacy
of
ROS‐involved
tumor
is
greatly
restricted
by
complex
microenvironment
(TME).
Herein,
a
dual‐metal
CaO
2
@CDs‐Fe
(CCF)
nanosphere,
with
TME
response
and
regulation
capabilities,
are
proposed
to
improve
ROS
lethal
power
multiple
cascade
synergistic
therapeutic
strategy
domino
effect.
In
weak
acidic
TME,
CCF
will
decompose,
accompanied
intracellular
Ca
2+
upregulated
abundant
H
O
produced
reverse
antitherapeutic
TME.
Then
exposed
CF
cores
can
act
as
both
Fenton
agent
sonosensitizer
generate
excessive
regulated
for
enhanced
CDT/SDT.
combination
calcium
overloading,
augmented
induced
oxidative
stress
cause
more
severe
mitochondrial
damage
cellular
apoptosis.
Furthermore,
also
reduce
GPX4
expression
enlarge
lipid
peroxidation,
causing
ferroptosis
apoptosis
parallel.
These
signals
finally
initiate
damage‐associated
molecular
patterns
activate
immune
realize
excellent
antitumor
This
outstanding
ROS/calcium
loading
effect
endows
anticancer
efficiently
eliminate
apoptosis/ferroptosis/ICD
vitro
vivo.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: June 15, 2024
Manganese
(Mn)
is
widely
recognized
owing
to
its
low
cost,
non-toxic
nature,
and
versatile
oxidation
states,
leading
the
emergence
of
various
Mn-based
nanomaterials
with
applications
across
diverse
fields,
particularly
in
tumor
diagnosis
therapy.
Systematic
reviews
specifically
addressing
therapy
aspects
Mn-derived
biomaterials
are
lacking.
This
review
comprehensively
explores
physicochemical
characteristics
synthesis
methods
biomaterials,
emphasizing
their
role
diagnostics,
including
magnetic
resonance
imaging,
photoacoustic
photothermal
ultrasound
multimodal
biodetection.
Moreover,
advantages
materials
treatment
discussed,
drug
delivery,
microenvironment
regulation,
synergistic
photothermal,
photodynamic,
chemodynamic
therapies,
immunotherapy,
imaging-guided
The
concludes
by
providing
insights
into
current
landscape
future
directions
for
Mn-driven
advancements
field,
serving
as
a
comprehensive
resource
researchers
clinicians.
ACS Applied Nano Materials,
Journal Year:
2024,
Volume and Issue:
7(16), P. 18932 - 18942
Published: Aug. 9, 2024
Cancer
cells
with
their
distinct
energy
supply
and
metabolic
patterns
offer
unique
opportunities
for
targeted
therapy
development.
This
study
presents
pH/ROS
dual-responsive
enzyme-carrying
nanoparticles
efficient
starvation
oxidative
in
cancer
treatment.
The
nanoparticles,
composed
of
zeolitic
imidazolate
framework-8
(ZIF-8),
glucose
oxidase
(GOx),
hyaluronic
acid
(HA),
were
designed
to
leverage
the
characteristics
cells.
GOx
was
covalently
modified
onto
HA
create
HA-GOx,
demonstrating
enhanced
enzymatic
activity
thermal
stability
compared
free
GOx.
ZIF@HAgel-GOx
then
synthesized
by
adsorbing
HA-GOx
ZIF-8
crosslinking
a
ROS-sensitive
crosslinker,
acetone-[bis-(2-amino-ethyl)-dithioacetal]
(TK).
properties
solution
comparable
those
GOx,
both
could
consume
catalyze
reaction.
produced
H2O2
decrosslink
gel
layer
ZIF@HAgel-GOx,
gluconic
degrade
core,
eventually
leading
complete
disassembly
ZIF@HAgel-GOx.
Cytotoxicity
assays
revealed
that
GOx-carrying
exhibited
superior
cytotoxicity
DOX
carriers
effectively
eliminate
minimal
dosage.
findings
provide
scientific
rationale
use
enzyme-based
therapies
treatment
various
diseases.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(17), P. 4097 - 4117
Published: Jan. 1, 2024
Manganese-based
nanoparticles
exhibit
the
multiple
roles
of
immune
adjuvants,
photosensitizers
and
photothermal
agents
in
photo-immunotherapy,
enhancing
anti-tumor
immunity
through
ways.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 9, 2024
Abstract
The
existence
of
the
blood–brain
barrier
(BBB)
and
characteristics
immunosuppressive
microenvironment
in
glioblastoma
(GBM)
present
significant
challenges
for
targeted
GBM
therapy.
To
address
this,
a
biomimetic
hybrid
cell
membrane‐modified
dual‐driven
heterojunction
nanomotor
(HM@MnO
2
‐AuNR‐SiO
)
is
proposed
treatment.
These
nanomotors
are
designed
to
bypass
BBB
target
glioma
regions
by
mimicking
surface
macrophage
membranes.
More
importantly,
MnO
structure
enables
propulsion
through
near‐infrared‐II
(NIR‐II)
light
oxygen
bubbles,
allowing
effective
treatment
at
deep
tumor
sites.
Meanwhile,
plasmonic
AuNR‐MnO
heterostructure
facilitates
separation
electron–hole
pairs
generates
reactive
species
(ROS),
inducing
immunogenic
death
under
NIR‐II
laser
irradiation.
Furthermore,
reacts
release
Mn
2+
ions,
activating
cGAS‐STING
pathway
enhancing
antitumor
immunity.
In
vitro
vivo
experiments
demonstrate
that
these
achieve
active
targeting
infiltration,
promoting
M1
polarization,
dendritic
maturation,
effector
T‐cell
activation,
thereby
catalysis
immunotherapy
ROS
production
STING
activation.